scispace - formally typeset
S

Suzan Can

Researcher at Heidelberg University

Publications -  18
Citations -  1209

Suzan Can is an academic researcher from Heidelberg University. The author has contributed to research in topics: Thioredoxin reductase & Cancer cell. The author has an hindex of 13, co-authored 17 publications receiving 1066 citations.

Papers
More filters
Journal ArticleDOI

Comparative in Vitro Evaluation of N-Heterocyclic Carbene Gold(I) Complexes of the Benzimidazolylidene Type

TL;DR: Remarkable antiproliferative effects, a strong induction of apoptosis, and enhancement of reactive oxygen species (ROS) formation as well as other effects on tumor cell metabolism confirmed the promising potential of the complexes as novel anticancer chemotherapeutics.
Journal ArticleDOI

On the biological properties of alkynyl phosphine gold(I) complexes.

TL;DR: A pilot study aimed at establishing the biological profile of alkynyl phosphine gold(I) complexes shows that the critical target enzyme thioredoxin reductase can be efficiently and selectively inhibited and that cysteine and selenocysteine residues are presumably the sites of molecular interaction with the enzyme.
Journal ArticleDOI

A TrxR inhibiting gold(I) NHC complex induces apoptosis through ASK1-p38-MAPK signaling in pancreatic cancer cells

TL;DR: The data demonstrate that MC3 efficiently suppressed cell growth, and induced cell cycle arrest and apoptosis in pancreatic cancer cells, in particular in the gemcitabine-resistant cancer cells Panc1 and ASPC1.
Journal ArticleDOI

A spontaneous gold(I)-azide alkyne cycloaddition reaction yields gold-peptide bioconjugates which overcome cisplatin resistance in a p53-mutant cancer cell line

TL;DR: Intriguingly, cisplatin-resistance in p53-mutant MDA-MB231 breast cancer cells could be overcome by the Au-peptide conjugates presented here, as indicated by flow cytometry, low mitochondrial membrane potential (MMP) and DNA fragmentation.